Oddrun Elise Olsen

868 total citations
24 papers, 556 citations indexed

About

Oddrun Elise Olsen is a scholar working on Molecular Biology, Rheumatology and Surgery. According to data from OpenAlex, Oddrun Elise Olsen has authored 24 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Oddrun Elise Olsen's work include TGF-β signaling in diseases (6 papers), Heterotopic Ossification and Related Conditions (4 papers) and Autopsy Techniques and Outcomes (3 papers). Oddrun Elise Olsen is often cited by papers focused on TGF-β signaling in diseases (6 papers), Heterotopic Ossification and Related Conditions (4 papers) and Autopsy Techniques and Outcomes (3 papers). Oddrun Elise Olsen collaborates with scholars based in Norway, United Kingdom and Sweden. Oddrun Elise Olsen's co-authors include Toril Holien, Anders Sundan, Hanne Hella, Anders Waage, Berit Størdal, Ingemar Turesson, Anne K. Mylin, Karin Fahl Wader, Kristine Misund and Ingerid Nesthus and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Oddrun Elise Olsen

24 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oddrun Elise Olsen Norway 12 302 144 114 76 69 24 556
Sébastien Bender France 16 552 1.8× 72 0.5× 37 0.3× 56 0.7× 29 0.4× 36 756
N. Fehse Germany 8 149 0.5× 47 0.3× 30 0.3× 53 0.7× 68 1.0× 11 595
Marie Jarošová Czechia 17 264 0.9× 84 0.6× 95 0.8× 13 0.2× 22 0.3× 87 766
Chikako Ohwada Japan 16 104 0.3× 74 0.5× 36 0.3× 26 0.3× 39 0.6× 63 691
Vera Paulson United States 12 200 0.7× 97 0.7× 226 2.0× 113 1.5× 14 0.2× 43 710
J P Grünfeld France 10 205 0.7× 49 0.3× 72 0.6× 17 0.2× 24 0.3× 16 477
John P. Garton United States 10 224 0.7× 55 0.4× 41 0.4× 34 0.4× 26 0.4× 11 570
Dragomir Marisavljević Serbia 16 119 0.4× 139 1.0× 48 0.4× 26 0.3× 16 0.2× 69 650
Aldona Woźniak Poland 14 127 0.4× 51 0.4× 96 0.8× 84 1.1× 12 0.2× 58 512
Xiaobing Niu China 16 686 2.3× 67 0.5× 86 0.8× 12 0.2× 39 0.6× 37 979

Countries citing papers authored by Oddrun Elise Olsen

Since Specialization
Citations

This map shows the geographic impact of Oddrun Elise Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oddrun Elise Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oddrun Elise Olsen more than expected).

Fields of papers citing papers by Oddrun Elise Olsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oddrun Elise Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oddrun Elise Olsen. The network helps show where Oddrun Elise Olsen may publish in the future.

Co-authorship network of co-authors of Oddrun Elise Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of Oddrun Elise Olsen. A scholar is included among the top collaborators of Oddrun Elise Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oddrun Elise Olsen. Oddrun Elise Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Bin, Paul D. Upton, Oddrun Elise Olsen, et al.. (2023). High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells. Scientific Reports. 13(1). 6639–6639. 2 indexed citations
3.
Jatzlau, Jerome, Hanne Hella, Oddrun Elise Olsen, et al.. (2023). FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells. Cell Communication and Signaling. 21(1). 25–25. 4 indexed citations
4.
Olsen, Oddrun Elise, et al.. (2020). RNA-Integrity and 8-Isoprostane Levels Are Stable in Prostate Tissue Samples Upon Long-Term Storage at −80°C. Biopreservation and Biobanking. 19(1). 2–10. 3 indexed citations
5.
Olsen, Oddrun Elise, et al.. (2020). Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors. Biomolecules. 10(4). 519–519. 38 indexed citations
6.
Pritchard‐Jones, Kathy, Harm van Tinteren, Jesper Brok, et al.. (2019). International comparisons of clinical demographics and outcomes in the SIOP Wilms tumour 2001 trial and study (2002-2011). 1 indexed citations
7.
Olsen, Oddrun Elise, Hanne Hella, Glenn Buene, et al.. (2018). BMPR2 inhibits activin and BMP signaling via wild-type ALK2. Journal of Cell Science. 131(11). 42 indexed citations
8.
Olsen, Oddrun Elise, et al.. (2018). First person – Oddrun Elise Olsen. Journal of Cell Science. 131(11). 1 indexed citations
9.
Olsen, Oddrun Elise, et al.. (2017). TGF-β contamination of purified recombinant GDF15. PLoS ONE. 12(11). e0187349–e0187349. 68 indexed citations
10.
Olsen, Oddrun Elise, Karin Fahl Wader, Hanne Hella, et al.. (2015). Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B. Cell Communication and Signaling. 13(1). 27–27. 124 indexed citations
11.
Holien, Toril, Kristine Misund, Oddrun Elise Olsen, et al.. (2015). MYCamplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy. Oncotarget. 6(26). 22698–22705. 21 indexed citations
12.
Olsen, Oddrun Elise, Karin Fahl Wader, Kristine Misund, et al.. (2014). Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin. Blood Cancer Journal. 4(3). e196–e196. 40 indexed citations
13.
Parkar, Anagha P., Oddrun Elise Olsen, H Maartmann-Moe, et al.. (2009). Antenatal ultrasound and postnatal autopsy findings in terminations after 12 weeks’ gestation due to fetal abnormality: population-based study in western norway, 1988–2002. Acta Radiologica. 50(7). 816–822. 6 indexed citations
14.
Lumsden, Daniel E., et al.. (2009). Pulmonary mass in an infant. European Respiratory Journal. 33(3). 694–699. 1 indexed citations
15.
Olsen, Oddrun Elise & Neil J. Sebire. (2006). Apparent diffusion coefficient maps of pediatric mass lesions with free-breathing diffusion-weighted magnetic resonance: feasibility study. Acta Radiologica. 47(2). 198–204. 15 indexed citations
16.
Scott, Richard H., Lynn M. Walker, Oddrun Elise Olsen, et al.. (2006). Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Archives of Disease in Childhood. 91(12). 995–999. 87 indexed citations
17.
Sen, G., Neil J. Sebire, Oddrun Elise Olsen, Edward M. Kiely, & Gill Levitt. (2006). Familial Currarino syndrome presenting with peripheral primitive neuroectodermal tumour arising with a sacral teratoma. Pediatric Blood & Cancer. 50(1). 172–175. 11 indexed citations
18.
McHugh, Kieran, Oddrun Elise Olsen, & Ashok Vellodi. (2004). Gaucher disease in children: radiology of non-central nervous system manifestations. Clinical Radiology. 59(2). 117–123. 17 indexed citations
19.
Olsen, Oddrun Elise, et al.. (2003). Diagnostic value of radiography in cases of perinatal death: a population based study. Archives of Disease in Childhood Fetal & Neonatal. 88(6). F521–F524. 25 indexed citations
20.
Olsen, Oddrun Elise & Peter C Gøtzsche. (1996). [The necessity of electronically updated meta-analyses: Doppler ultrasound in obstetrics as an example].. PubMed. 159(1). 27–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sébastien Bender Breakdown of academic impact, for papers by N. Fehse Breakdown of academic impact, for papers by Marie Jarošová Breakdown of academic impact, for papers by Chikako Ohwada Breakdown of academic impact, for papers by Vera Paulson Breakdown of academic impact, for papers by J P Grünfeld Breakdown of academic impact, for papers by John P. Garton Breakdown of academic impact, for papers by Dragomir Marisavljević Breakdown of academic impact, for papers by Aldona Woźniak Breakdown of academic impact, for papers by Xiaobing Niu
Rankless by CCL
2026